Chronic myeloid leukaemia in a patient with psoriasis following bimolane treatment

J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e66-e67. doi: 10.1111/jdv.15915. Epub 2019 Sep 16.

Authors

Y Gu¹, K Li¹, Y Zhou², J Zhang¹

Affiliations

¹ Department of Dermatology, Peking University People's Hospital, Beijing, China.
² Department of Hematology, Peking University People's Hospital, Beijing, China.

PMID: 31465597
DOI: 10.1111/jdv.15915

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / therapeutic use
Dermatologic Agents / adverse effects
Dermatologic Agents / therapeutic use*
Humans
Imatinib Mesylate / therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / chemically induced*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Psoriasis / drug therapy*
Razoxane / analogs & derivatives*
Razoxane / therapeutic use

Substances

Antineoplastic Agents
Dermatologic Agents
bimolane
Razoxane
Imatinib Mesylate